Indinavir use: Associated reversible hair loss and mood disturbance

International Journal of STD and AIDS

Volumn 11, Issue 7, 2000, Pages 474-476

  Harry, Tubonye C ^a   Matthews, Mime ^a   Salvary, Ingrid ^a  

^a JAMES PAGET UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adverse drug reactions; Alopecia; Depression; Indinavir

Indexed keywords

ANTIVIRUS AGENT; INDINAVIR; NELFINAVIR;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CASE REPORT; HAIR LOSS; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL;

ALOPECIA; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; IRRITABLE MOOD; MALE; MIDDLE AGED;

EID: 0034051343     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462001916146     Document Type: Article

References (5)

1. 1 Barczak P, Kane N, Andrews S, et al. Patterns of psychiatric morbidity in a genitourinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry 1988;152:698-700
2. 2 D'Arminio Monforte A, Testa L, Gianotto M, et al. Indinavir related alopecia. AIDS 1998;12:328
3. 3 Bouscarat F, Prevot M, Matheron S. Alopecia associated with indinavir therapy. N Engl J Med 1999;341:618
4. 4 Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998;351:181-3
5. 5 Lenhard JM, Weiel JE, Paulik MA., et al. Indinavir enhances retinoic acid signaling: nelfinavir, saquinavir, and ritonavir inhibit retinoid effects in vitro. Presented at the 6th Conference on Retroviruses and Opportunistic Infection, Chicago, 1-5 February 1999